Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS Q2041 · per UP TO 200 MILLION CAR T CELLS

Axicabtagene ciloleucel car+

Products billed under this code include Yescarta.

Payment limit per UP TO 200 MILLION CAR T CELLS, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q2041

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Yescarta Gilead Sciences, Inc. 71287-0119-01 1 $577,943.258

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $577,943.258 +$15,442.366 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted September 17, 2026
3Q26 $562,500.892 +$30,651.774 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted September 15, 2026
2Q26 $531,849.118 −$343.123 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted September 15, 2026
1Q26 $532,192.241 −$1,037.93 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted September 15, 2026
4Q25 $533,230.171 +$153.695 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted September 8, 2026
3Q25 $533,076.476 +$30,235.748 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted March 10, 2026
2Q25 $502,840.728 +$13,323.577 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted March 10, 2026
1Q25 $489,517.151 +$61.193 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted December 19, 2025
4Q24 $489,455.958 +$319.048 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted June 11, 2025
3Q24 $489,136.91 +$29,755.464 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted June 11, 2025
2Q24 $459,381.446 +$9,941.446 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted March 11, 2025
1Q24 $449,440.00 +$98.149 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted December 19, 2024
4Q23 $449,341.851 −$98.149 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted October 10, 2024
3Q23 $449,440.00 +$194.139 UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted June 5, 2024
2Q23 $449,245.861 – UP TO 200 MILLION CAR T CELLS Axicabtagene ciloleucel car+ v1, posted February 23, 2024

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files